NALIDIXIC ACID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nalidixic Acid, and when can generic versions of Nalidixic Acid launch?
Nalidixic Acid is a drug marketed by Sun Pharm Industries and Watson Labs and is included in six NDAs.
The generic ingredient in NALIDIXIC ACID is nalidixic acid. There is one drug master file entry for this compound. Additional details are available on the nalidixic acid profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NALIDIXIC ACID?
- What are the global sales for NALIDIXIC ACID?
- What is Average Wholesale Price for NALIDIXIC ACID?
Summary for NALIDIXIC ACID
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 6 |
| Patent Applications: | 4,524 |
| DailyMed Link: | NALIDIXIC ACID at DailyMed |
Recent Clinical Trials for NALIDIXIC ACID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Albany Medical College | N/A |
| Alexandra Hospital, Athens, Greece | Phase 4 |
| Hellenic Society of Gastroenterology | Phase 4 |

